Supernus Pharmaceuticals | SUPN - Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Cara Therapeutics USD 0 0 2025-03
Eisai JPY 134.77B 12M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Novo Nordisk DKK 118.94B 29.76B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
United Therapeutics USD 100M 100M 2024-06
Xeris Pharmaceuticals USD 220.33M 866K 2025-12